Spectrum of early onset nephrotic syndrome associated with WT1 missense mutations

Kidney International

Volumn 53, Issue 6, 1998, Pages 1594-1600

  Schumacher, Valérie ^b   Schärer, Karl ^b   Wühl, Elke ^b   Altrogge, Hans ^b   Bonzel, Klaus E ^b   Guschmann, Michael ^b   Neuhaus, Thomas J ^b   Pollastro, Rosa M ^b   Kuwertz Bröking, Eberhard ^b   Bulla, Monika ^b   Tondera, Andrea M ^b   Mundel, Peter ^b   Helmchen, Udo ^b   Waldherr, Rüdiger ^b   Weirich, Angela ^b   Royer Pokora, Brigitte ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b NONE

Author keywords

Denys Drash syndrome; Diffuse mesangial sclerosis; Nephrotic syndrome; Renal failure; Wilms' tumor

Indexed keywords

CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONFERENCE PAPER; DENYS DRASH SYNDROME; ENZYME ANALYSIS; EXON; GENOTYPE; HUMAN; KIDNEY BIOPSY; KIDNEY FAILURE; MISSENSE MUTATION; NEPHROBLASTOMA; NEPHROTIC SYNDROME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 7144261709     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00948.x     Document Type: Conference Paper

References (44)

1. DENYS P, MALVAUX P, VAN DEN BERGHE H, TANGHE W, PROESMANS W: Association d'un syndrome anatomopathologique de pseudohermaphrodisme masculin, d'une tumeur de Wilms, d'une néphropathie parenchymateuse et d'un mosaicisme XX/XY. Arch Franc Pediat 24:729-739, 1967
2. DRASH A, SHERMAN F, HARTMANN W, BLIZZARD R: A syndrome of pseudohermaphroditism, Wilms' tumor, hypertension, and degenerative renal disease. J Pediatr 76:585-593, 1970
3. HABIB R, LOIRAT C, GUBLER MC, NIAUDET P, BENSMAN A, LEVY M, BROYER M: The nephropathy associated with male pseudohermaphroditism and Wilms' tumor (Drash syndrome): A distinctive glomerular lesion-report of 10 cases. Clin Nephrol 24:269-278, 1985
4. JADRESIC L, LEAKE J, GORDON I, DILLON MJ, GRANT DB, PRITCHARD J, RISDON RA, BARRATT TM: Clinicopathologic review of twelve children with nephropathy, Wilms' tumor, and genital abnormalities (Drash syndrome). J Pediatr 117:717-725, 1990
5. MANIVEL J, RICHARD MD, SIBLEY K, DEHNER L: Complete and incomplete Drash syndrome. Hum Pathol 18:80-89, 1987
6. HABIH R: Nephrotic syndrome in the 1st year of life. Ped Nephrol 7:336-346, 1993
7. CALL KM, GLASER T, ITO CY, BUCKLER AJ, PELLETIER J, HABER DA, ROSE EA, KRAL A, YEGER H, LEWIS WH, JONES C, HOUSMAN DE: Isolation and characterization of a zinc finger polypeptide gene at human chromosome 11 Wilms' tumor locus. Cell 60:509-520, 1990
8. GESSLER M, POUSTKA A, CAVENEE W, NEVE RL, ORKIN SH, BRUNS GAP: Homozygous deletion in Wilms' tumours of a zink finger gene identified by chromosome jumping. Nature 343:774-778, 1990
9. HABER DA, SOHN RL, BUCKLER M, PELLETIER J, CALL KM, HOUSMAN DE: Alternative splicing and genomic structure of the Wilms' tumor gene WT1. Proc Natl Acad Sci USA 88:9618-9622, 1991
10. BRENNER B, WILDHARDT G, SCHNEIDER S, ROYER-POKORA B: RNA polymerase chain reaction detects different levels of four alternatively spliced WT1 transcripts in Wilms' tumors. Oncogene 7:1431-1433, 1992
11. LITTLE M, WELLS C: A clinical overview of WT1 gene mutations. Hum Mutation 9:209-225, 1997
12. PRITCHARD-JONES K, FLEMING S, DAVIDSON D, BICKMORE W, PORTEOUS D, GOSDEN C, BARD J, BUCKLER A, PELLETIER J, HOUSMAN D, VAN HEYNINGEN V, HASTIE N: The candidate Wilms' tumour gene is involved in genitourinary development. Nature 346:194-197, 1990
13. PELLETIER J, BRUENING W, LI FP, HABER DA, GLASER T, HOUSMAN DE: WT1 mutations contribute to abnormal genital system development and hereditary Wilms' tumour. Nature 353:431-434, 1991
14. PRITCHARD-JONES K, FLEMING S: Cell types expressing the Wilms' tumour gene (WT1) in Wilms' tumours: Implication for tumour histogenesis. Oncogene 6:2211-2220, 1991
15. MUNDLOS S, PELLETIER J, DARVEAU A, BACHMANN M, WINTERPRACHT A, ZABEL B: Nuclear localization of the protein encoded by the Wilms' tumor gene WT1 in embryonic and adult tissues. Development 119:1329-1341, 1993
16. KREIDBERG J, SARIOLA H, LORING J, MAEDA M, PELLETIER J, HOUSMAN D, JAENISCH R: WT-1 is required for early kidney development. Cell 74:679-691, 1993
17. PELLETIER J, BRUENING W, KASHTAN CE, MAUER SM, MANIVEL JC, STRIEGEL JE, HOUGHTON C, JUNIEN C, HABIB R, FOUSER L, FINE RN, SILVERMAN BL, HABER DA, HOUSMAN D: Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 67:437-447, 1991
18. BAIRD PN, COWELL JK: A novel zinc finger mutation in a patient with Denys-Drash syndrome. Hum Mol Genet 2:2193-2194, 1993
19. TSUDA M, SAKIYAMA T, KITAGAWA T, WATANABE S, WATANABE T, TAKAHASHI S, KAWAGUCHI H, ITO K: Molecular analysis of two Japanese cases of Denys-Drash syndrome. J Inher Metab Dis 16:876-880, 1993
20. NORDENSKJÖLD A, FRIEDMAN E, ANVRET M: WT1 mutations in patients with Denys-Drash syndrome: A novel muatation in exon 8 and paternal allele origin. Hum Genet 93:115-120, 1994
21. SCHMITT K, ZABEL B, TULZER G, EITELBERGER F, PELLETIER J: Nephropathy with Wilms' tumour or gonadal dysgenesis: Incomplete Denys-Drash syndrome or separate disease? Eur J Pediatr 154:577-581, 1995
22. TSUDA M, SAKIYAMA T, OWADA M, CHIBA Y: A newly identified exonic mutation of the WT1 gene in a patient with Denys-Drash syndrome. Acta Ped Jap 38:265-266, 1996
23. DEVRIENDT K, DELOOF E, MOERMAN P, LEGIUS E, VANHOLE C, DE ZEGHER F, PROESMANS W, DEVLIEGER H: Diaphragmatic hernia in Denys-Drash syndrome. Am J Med Genet 57:97-101, 1995
24. BARDEESY N, ZABEL B, SCHMITT K, PELLETIER J: WT1 mutations associated with incomplete Denys-Drash syndrome define a domain predicted to behave in a dominant-negative fashion. Genomics 21: 663-665, 1993
25. BRUENING W, BARDEESY N, SILVERMAN BL, COHN RA, MACHIN GA, ARONSON AJ, HOUSMAN D, PELLETIER J: Germline intronic and exonic mutations in the Wilm's tumour gene (WT1) affecting urogenital development. Nature Genet 1:144-148, 1992
26. SAKAI A, TADOKORO K, YANAGISAWA M: A novel mutation of the WT1 gene (a tumor suppressor gene for Wilms' tumor) in a patient with Denys-Drash syndrome. Hum Mol Genet 2:1969-1979, 1993
27. LITTLE MH, WILLIAMSON KA, MANNENS M, KELSEY A, GOSDEN C, HASTIF ND, VAN HEYNINGEN V: Evidence that WT1 mutations in Denys-Drash syndrome patients may act in a dominant-negative fashion. Hum Mol Genet 2:259-264, 1993
28. GHAKEMANI M, CHAN C-B, BISTRITZER T, ALADJEM M, TIEDER M, PELLETIER J: A novel mutation H373Y in the Wilms' tumor suppressor gene, WT1, associated with Denys-Drash syndrome. Hum Hered 46:336-338, 1996
29. COPPES MJ, LIEFFERS GJ, HIGUCHI M, ZINN AB, BALFE JW, WILLIAMS BRG: Inherited WT1 mutation in Denys-Drash syndrome. Cancer Res 52:6125-6128, 1992
30. OGAWA O, ECCLES, MR, YUN K, MUELLER RF, HOLDAWAY MDD, REEVE AE: A novel insertional mutation at the third zinc finger coding region of the WT1 gene in Denys-Drash syndrome. Hum Mol Genet 2:203-204, 1992
31. BAIRD PN, SANTOS A, GROVES N, JADRESIC L, COWELL JK: Constitutional mutations in the WT1 gene in patients with Denys-Drash syndrome. Hum Mol Genet 1:301-305, 1992
32. WEBB NJA, LEWIS MA, WILLIAMSON K, VAN HEYNINGEN V, BRUCE J, LENDON M, POSTLETHWAITE RJ: Do children with diffuse messangial sclerosis in association with mutations of the Wilms' tumour suppressor gene (WT1) require bilateral nephrectomy? Pediatr Nephrol 9:252-253, 1995
33. KÖNIG A, JAKUBICZKA S, WIEACKER P, SCHLOSSER H, GESSLER M: Further evidence that imbalances of the WT1 isoforms may be involved in Denys-Drash syndrome. Hum Mol Genet 2:1967-1968, 1993
34. POULAT F, MORIN D, KÖNIG A, BRUN P, GILTAY J, SULTAN C, DUMAS R, GESSLER M, BERTA P: Distinct molecular origins for Denys-Drash and Frasier syndromes. Hum Genet 91:285-286, 1993
35. MUELLER RF: The Denys-Drash syndrome. J Med Genet 31:471-477, 1994
36. SCHUMACHER V, SCHNEIDER S, FIGGE A, WILDHARDT G, HARMS D, SCHMIDT D, WEIRICH A, LUDWIG R, ROYER-POKORA B: Correlation of germ-line mutations and two hit inactivation of the WT1 gene with Wilms tumors of stromal-predominant histology. Proc Natl Acad Sci USA 94:3972-3977, 1997
37. ORITA M, SUZUKI Y, SEKIYA T, HAYASHI K: Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 5:874-879, 1989
38. COPPES MJ, HUFF V, PELLETIER J: Denys-Drash syndrome: Relating a clinical disorder to genetic alterations in the tumor suppressor gene WT1. J Pediatr 123:673-678, 1993
39. BARBAUX S, NIAUDET P, GUBLER M-C, GRÜNFELD J-P, JAUBERT F, KUTTENN F, FÉKÉTE C, SOULEYREAU-THERVILLE N, THIBAUD E, FELLOUS M, MCELREAVEY K: Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Nature Genet 17:467-470, 1997
40. SCHNEIDER S, WILDHARDT G, LUDWIG R, ROYER-POKORA B: A donor splice site mutation in the Wilms tumor gene WT-1 results in exon skipping and is associated with Wilms' tumor and genital malformations. Human Genet 91:599-604, 1993
41. EDIDIN DV: Pseudohermaphroditism, glomerulopathy, and Wilms tumor (Drash syndrome), (abstract) J Pediatr 107:988, 1985
42. HABIB R, GUBLER MC, ANTIGNAC C, LOIRAT C, GAGNADOUX MF: Syndrome néphrotique congénital ou infantile avec sclerose mesangiale diffuse. Ann Pediatr (Paris) 37:73-77, 1990
43. HABIB R, GUBLER M-C, ANTIGNAC C, GAGNADOUX MF: Diffuse mesangial sclerosis: A congenital glomerulopathy with nephrotic syndrome, in Advances in Nephrology (vol 22), St. Louis, Mosby Year Book Inc., 1993, pp 43-57
44. FUCHSHUBER A, JEAN G, GRIBOUVAL O, GUBLER M-C, BROYER M, BECKMANN J, NIAUDET P, ANTIGNAC C: Maping a gene (SRN1) to chromosome 1q25-q31 in idiopathic nephrotic syndrome confirms a distinct entity of autosomal recessive nephrosis. Hum Mol Genet 4:2155-2158, 1995